Canada markets closed

EyePoint Pharmaceuticals, Inc. (EYPT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
9.38+0.09 (+0.97%)
At close: 04:00PM EDT
9.56 +0.18 (+1.92%)
After hours: 07:02PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 488.55M
Enterprise Value 193.83M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)8.02
Price/Book (mrq)1.95
Enterprise Value/Revenue 3.88
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.60
52-Week Change 335.94%
S&P500 52-Week Change 323.76%
52 Week High 330.99
52 Week Low 35.67
50-Day Moving Average 314.44
200-Day Moving Average 316.14

Share Statistics

Avg Vol (3 month) 31.11M
Avg Vol (10 day) 31.02M
Shares Outstanding 552.08M
Implied Shares Outstanding 652.08M
Float 834.22M
% Held by Insiders 11.41%
% Held by Institutions 1110.93%
Shares Short (May 15, 2024) 48.13M
Short Ratio (May 15, 2024) 44.88
Short % of Float (May 15, 2024) 418.40%
Short % of Shares Outstanding (May 15, 2024) 415.62%
Shares Short (prior month Apr 15, 2024) 46.54M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 09, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Dec 09, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -157.77%
Operating Margin (ttm)-285.19%

Management Effectiveness

Return on Assets (ttm)-22.12%
Return on Equity (ttm)-48.07%

Income Statement

Revenue (ttm)50.02M
Revenue Per Share (ttm)1.17
Quarterly Revenue Growth (yoy)52.10%
Gross Profit (ttm)N/A
EBITDA -84.97M
Net Income Avi to Common (ttm)-78.92M
Diluted EPS (ttm)-1.81
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)299.35M
Total Cash Per Share (mrq)5.75
Total Debt (mrq)5.72M
Total Debt/Equity (mrq)2.29%
Current Ratio (mrq)5.08
Book Value Per Share (mrq)5.01

Cash Flow Statement

Operating Cash Flow (ttm)-12.46M
Levered Free Cash Flow (ttm)9.88M